What move does the options market price into Immunovant's report?

Implied ±10.4%, either direction.

How often does Immunovant move more than the options market prices?

1 of the last 8 reports moved at least as far as the implied move.

IMVTNasdaqBiological Products, (No Diagnostic Substances)

Immunovant, Inc. (IMVT) earnings date, market-implied expected move, and options open interest by expiry

28.41

0.00 · 0.00%

post 29.00 +2.08%

Closed15:59 ET

Open28.80Volume1.3MMkt cap$5.9BEPS-2.81

Day28.20 – 29.2576%52-wk21.43 – 45.4232%

IMVT

Immunovant, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±10.4%implied · straddle

26.0232.06

spot 29.04exp Nov 20ATM strike 29ATM straddle 3.55IV 71%

Nov 3 close

Expected move

Inputs

Next report

Nov 9

before open · in 5 days

est.Q2 FY27

Calendar

Next report

Last report

+1.17%

vs ±9.0% implied · ×0.13

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

13dROIV · supplierStocks making the biggest moves midday: SpaceX, Meta Platforms, Super Micro Computer, Roivant Sciences & more

News

Largest filed tie

13F top-10 QoQ

+4.59%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

227 managers

Top fund weight

0.92%

IMVT weight · XBI

N-PORTJun 30 '26

5 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Immunovant (IMVT) is expected to report on Nov 9 before open (estimated date).

Implied vs realized

8 reports

1 of 8≥ implied

avg implied: ±13.7%
avg realized: ±9.2%

Nov 7 '24Nov 7 '24confirmed±8.5%▼−4.74%×0.56

Feb 6 '25Feb 6 '25confirmed±16.5%▼−9.55%×0.58

May 29 '25May 29 '25confirmed±16.1%▲+5.60%×0.35

Aug 11 '25Aug 11 '25confirmed±13.9%▼−4.53%×0.32

Nov 10 '25Nov 10 '25confirmed±16.2%▲+0.09%×0.01

Q3 FY26Feb 6 '26confirmed±13.5%▲+12.43%×0.92

May 20 '26May 20 '26confirmed±15.6%▲+35.26%×2.26

Q1 FY27Aug 6 '26confirmed±9.0%▲+1.17%×0.13

quarterimplied−40%0+40%realized×

Q1 FY27±9.0%▲+1.17%×0.13

May '26±15.6%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Nov 3 close

0.51OI · 5 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

315+72%Nov 2016d612+97%

1,706+141%Dec 1844d0.1213,965+24%0.12

566+138%Jan 1572d0.88645+108%0.88

297+6%Mar 19135d0.0311,149+5%0.03

216+42%Apr 16163d2.5186+274%2.51

ExpiryPutsCallsP/C

Nov 2016d315+72%612+97%0.51

Dec 1844d1,706+141%13,965+24%0.12

Jan 1572d566+138%645+108%0.88

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±10.4%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Suppliers 1

ROIV±4.5%×0.43

Dashed = straddle · × = co-movement · max 500dMethod 1 more fund Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 3 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 15:45 ET

Intraday

Event sensitivity

PPI ×1.38· ±3.3% vs ±2.4% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±3.3%6 of 10×1.38

CPROFcorporate profits±2.3%10 of 12×0.97

FOMCrate decision±2.0%10 of 24×0.86

GDPgross domestic product±2.0%15 of 19×0.86

NFPjobs report±2.0%5 of 10×0.85

CPIconsumer prices±1.9%4 of 10×0.79

PCEpersonal income & outlays±1.6%11 of 19×0.68

Bar = avg |move| to ±4% · tick = ±2.4% avg day · ×base = |move| ÷ ±2.4% · min 6 releases

Earnings history

EPS -0.75 · consensus —

Quarter	Reported	EPS	Consensus
Q1 FY27	Aug 6 '26 · confirmed	-0.75	—
Q4 FY26	—	-0.72	—
Q3 FY26	Feb 6 '26 · confirmed	-0.61	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod